Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Lowered by 1858 Wealth Management LLC

1858 Wealth Management LLC cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,532 shares of the medical equipment provider’s stock after selling 52 shares during the quarter. Intuitive Surgical comprises 1.5% of 1858 Wealth Management LLC’s holdings, making the stock its 19th biggest position. 1858 Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,844,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the third quarter valued at approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.2 %

Shares of ISRG stock opened at $579.65 on Wednesday. The stock’s fifty day simple moving average is $551.24 and its 200-day simple moving average is $511.16. The company has a market capitalization of $206.46 billion, a price-to-earnings ratio of 90.43, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,843 shares of company stock valued at $15,357,560 in the last 90 days. 0.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ISRG. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. CICC Research started coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Finally, BTIG Research boosted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.